SpecificationsOrganism/cell line/tissueMus musculus cell suspensions from dorsal root gangliaSexMaleSequencer or array typecBot and HiSeq, IllunminaData formatRaw and processedExperimental factorsIsolated cell suspensions prepared from dorsal root ganglia (DRG) dissected from 6 adult GINIP^mCherry^ knock-in mice.Experimental featuresFACS sorting of MRGPRD +, C-LTMRs and a heterogeneous subset of DRG cell; RNA sequencing to study the gene expression profiles of each sorted subset.ConsentN/ASample source locationN/A

1. Direct link to deposited data {#s0005}
================================

Deposited data can be found here: <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE64091>.

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Identification and FACS-sorting of MRGPRD^+^ neurons, C-LTMRs and double negative DRG neurons {#s0015}
--------------------------------------------------------------------------------------------------

The FACS-sorting strategy takes advantage of the GINIP^mCherry^ mouse model in which the mCherry fluorescent protein is expressed at *Ginip* locus, allowing high fidelity identification of GINIP^+^ neurons through live mCherry fluorescence [@bb0020]. As shown in [Fig. 1](#f0005){ref-type="fig"}, combined analysis of GINIP and IB4 expression segregates dorsal root ganglia (DRG) neurons into 4 distinct subsets: GINIP^+^/IB4^+^ double positive (DP), GINIP^+^/IB4^−^, GINIP^−^/IB4^+^ simple positive (SP) and GINIP^−^/IB4^−^ double negative (DN) neurons. We have previously shown that DP neurons corresponded to the cutaneous MRGPRD^+^ free nerve endings that convey noxious touch [@bb0005], [@bb0020] and GINIP^+^/IB4^−^ to the C-LTMRs, involved in pleasant touch [@bb0010], [@bb0020], [@bb0025].

Briefly, GINIP^mCherry^ DRG cell suspensions were labeled with Alexa647-conjugated IB4 and with Sytox Blue dye for exclusion of dying cells prior to FACS sorting. DRG cells suspensions from wild-type (WT) mice were used as a negative control. Given that the final aim of this experiment is the extraction of high quality RNA from selected neuronal subsets, the fine calibration of the FACS experiment is a critical step. The basal fluorescence of DRG cell suspensions in the mCherry detection channel was determined by plotting the structure (SSC) parameter versus mCherry parameter of sample from WT animals ([Fig. 2](#f0010){ref-type="fig"}A). This allowed reliable and specific detection of mCherry-positive cells within the GINIP^mCherry^ sample ([Fig. 2](#f0010){ref-type="fig"}B--C). Further analysis enabled the elimination of dead and auto-fluorescent cells ([Fig. 2](#f0010){ref-type="fig"}D--E).

The FACS-gating strategy was as follows: we first defined (A) mCherry^−^ and (B) mCherry^+^--Sytox Blue^−^ living cell gates. SP and DN subsets were sorted from gate A and DP and C-LTMRs were sorted from gate B ([Fig. 2](#f0010){ref-type="fig"}E--F). Two independent FACS sorting experiments were performed to obtain two independent biological replicates.

2.2. RNA extraction and purity control {#s0020}
--------------------------------------

Cells were sorted directly in RLT lysis buffer from RNeasy Micro Kit (Quiagen) and total RNA was extracted according to manufacturer\'s instructions. Prior to RNA-seq, the purity of the 4 sorted samples and the eventual cross contaminations were evaluated by RT-PCR. The expression patterns of *Ginip*, *mCherry*, *Mrgprd*, *Tafa4*, *Trpv1* and *TrkA* transcripts were analyzed and found accurate (data not shown). However, SP cells were found to be highly contaminated by CD31-expressing endothelial cells that also bind IB4 and thus were excluded from the RNA-seq experiment (data not shown).The quality of the RNA obtained from each sorted sample was determined with respect to RNA profiles generated by the Agilent Bioanalyzer 2000 (Agilent Inc.).

2.3. RNA-Sequencing and quality control {#s0025}
---------------------------------------

For each sample, 50 ng of high quality total RNAs were amplified using the Amino Allyl Message Amp II amplification kit (Life Technologies) and 100 ng of resulting amplified RNAs were used for libraries building with TrueSeq Sample preparation (low throughput protocol) kit from Illumina. Libraries were sequenced in 100-bp paired-end cycles using the Illumina HiSeq2000 system with SBS technology. Image analysis and base calling were performed using the HiSeq Control Software and Real-Time Analysis component provided by Illumina. Quality of the sequencing was assessed using FastQC and the Illumina software SAV (Sequence Analysis Viewer); a representative example is shown in [Fig. 2](#f0010){ref-type="fig"}.

For each sample, the median and the mean distribution of the quality scores was above 30 and data acquisition was not affected by base loss ([Fig. 3](#f0015){ref-type="fig"}A--B and data not shown). Altogether, these criteria attest for the good quality of the RNA-seq experiment.

2.4. Data analysis {#s0030}
------------------

Base calling yielded between 40 and 50 million reads ([Table 1](#t0005){ref-type="table"}). RNA-seq reads were aligned to *Mus musculus* genome (UCSC mm10) using the eland_rna module from CASAVA (refFlat.txt file downloaded from UCSC on October 10, 2012). As CASAVA software is not designed for pair-end analysis, only the first pair was used to generate the counts. Reads mapping to contaminants including 28S, 18S and 5S ribosomal RNAs, mitochondrial chromosome, PhiX genome (Illumina control) and Illumina adaptors as well as reads mapping to multiple splicing positions and with no match, were removed. Gene counting was carried with the counting module from CASAVA. [Table 1](#t0005){ref-type="table"} gives an overview of the number of counts generated and shows those that mapped to exons that were used for the creation of the Raw Data file. Genes generating less than 10 counts were excluded from the subsequent statistical analysis.

The first normalization method used was the Reads Per Kilobase per Million of mapped reads (RPKM) [@bb0030]. Analysis of RPKM values generated for genes expected to be enriched in each defined subset, showed substantial and accurate enrichment in *Mrgprd* and *P2rx3* in DP subset *Tafa4* and *Th* in C-LTMRs and *Cgrp* and *Sp* in DP subset, providing a proof of concept of the RNA-seq data presented in our study ([Fig. 4](#f0020){ref-type="fig"}A).

Because our aim was to determine the sets of differentially expressed genes (DEGs) in one subset as compared to the two others and that the RPKM normalization method was shown to be inappropriate for such an analysis [@bb0015], we chose the Trimmed Mean of M-values (TMM) normalization factors provided by edgeR package (*p* \< 0,01, fold change \> 2). Smear-plot representation of pairwise comparison of TMM-normalized datasets showed that the log fold change (FC) was centered on zero, attesting that the libraries were correctly normalized (see [Fig. 4](#f0020){ref-type="fig"}B). 486 DEGs were declared enriched in DP as compared to the other subsets, 549 in C-LTMRs and 2916 in DN.

2.5. Data validation {#s0035}
--------------------

Only DEGs that generated at least 1000 reads in both biological replicates were kept for downstream data validation. As a result, data validation was carried on 156, 184 and 784 DP-, C-LTMRs- and DN-DEG, respectively. For this, we performed an extensive in situ hybridization (ISH) screen on DRG cryosections followed by either a) GINIP or IB4 immunostaining for DP and C-LTMRs datasets or b) GINIP and TrkA immunostaining for DN. The criteria for validation were the following: a) a gene declared enriched in DP should be detected by ISH as highly expressed in GINIP^+^/IB4^+^ neurons but excluded from GINIP^+^/IB4^−^ neurons; a) a gene declared enriched in C-LTMRs should exhibit the opposite expression pattern and c) a gene declared enriched in DN should be excluded from GINIP^+^ neurons.

We thus monitored the expression of 48 DP-, 68-C-LTMRs and 13-DN-enriched transcripts thereby confirming the validity of RNA-seq data generated in this study ([Fig. 5](#f0025){ref-type="fig"}A--B and data not shown). Moreover, we generated two open-access ISH libraries (DP ISH library: <http://www.ibdm.univ-mrs.fr/equipes/reynders/DP-ISHlibrary.pptx> and C-LTMRs ISH library: <http://www.ibdm.univ-mrs.fr/equipes/reynders/CLTMRs-ISHlibrary.pptx>) in which we provide the digital prevalence and the expression patterns of these genes in DRG neurons.

3. Discussion {#s0040}
=============

We described here a unique dataset encompassing the combinatorial gene expression enriched in MRGPRD^+^, C-LTMRs and DN DRG sensory neurons. We highlight here that our published RNA-seq data are of good quality and concordant with our validation strategy. These data provide a wealth of information regarding the presence and the prevalence of transcripts in MRGPRD^+^, C-LTMRs and DN sensory neurons, they highlight the differential gene expression in two functionally opposite classes of cutaneous afferents and they allow open-access monitoring the cellular distribution of over 100s of genes [@bb0035].

We are grateful to the members of the laboratory for scientific discussions, to M. Barad, A. Zouine and M. Malissen from CIML flow cytometry facility for FACS assistance. We thank S. Alonso for comments on the manuscript, M. Deage for the pilot experiment on Tafa4 DRG neurons as well as IBDM imaging and animal facilities for assistance. This work has been funded by ERC-Starting grant paineurons 260435 to A.M.

![Combined GINIP and IB4 immunolabeling allows discriminating 4 distinct subsets of DRG neurons.\
A --- Shows GINIP (red) and IB4 (green) immunostainings on DRG tissue section. Inset 1 shows GINIP^+^/IB4^+^ double positive (DP, yellow) and GINIP^+^/IB4^−^ (C-LTMRs, red) neurons. Inset 2 shows GINIP^−^/IB4^+^ simple positive (SP, green) and GINIP^−^/IB4^−^ double negative (DN, asterisk) neurons.\
B --- Schematic representation of GINIP/IB4 subsets.](gr1){#f0005}

![FACS-sorting strategy.\
A and D --- Representative dot plots of WT DRG cell suspensions used to determine the background level of mCherry fluorescence (A) and autofluorescence in mCherry and V500 channels (D).\
B --- Representative dot plots showing accurate mCherry gate positioning for mCherry^+^ cells sorting from GINIP^mCherry^ DRG cell suspensions.\
C --- Shows that IB4 labeling divides mCherry^+^ cells into IB4^+^ (DP) and IB4^−^ (C-LTMRs) subsets.\
E and F --- Shows the FACS gates used for sorting DP, C-LTMRs, SP and DN subsets from GINIP^mCherry^ mouse DRGcell suspension. mCherry^−^ autofluorescent/V500^−^ (A) and mCherry^+^ autofluorescent/V500^−^ (B) cells were further gated as depicted. mCherry^−^ IB4^+^(SP) and mCherry^−^ IB4^−^ (DN) subsets were sorted from gate A and mCherry^+^ IB4^+^(DP) and mCherry^+^ IB4^−^ (C-LTMRs) were sorted from gate B.](gr2){#f0010}

![Quality control of RNA-seq experiment.\
A --- Shows the quality scores (QS) distribution across all bases. The red line represents the median QS. B --- Shows the QS distribution across all sequences. The peak depicts the mean quality per sequence (Phred Score). Only one representative sample is illustrated herein.](gr3){#f0015}

![Data normalization with RPKM and TMM methods.\
A --- Shows the RPKM counts obtained for indicated genes that we expected to be enriched in DP (yellow), C-LTMRs (orange) and DN (gray) neurons.\
B --- Shows a representative fold change (FC) smear plot illustrating pairwise comparison of the libraries after normalization with TMM method (*p* \< 0.01, FC \> 2). DEGs are shown in red.](gr4){#f0020}

![Transcriptional profiles of DP and C-LTMRs.\
Summarizes the numbers of genes found enriched in DP (A) and C-LTMRs (B) subsets and provides an illustrative view of the open-access ISH libraries.](gr5){#f0025}

###### 

RNA-seq overview. Provides the total number of sequenced tags (clusters) and those that mapped to exons.

                    DP Sort no. l   DP Sort no. 2   C-LTMRs Sort no. l   C-LTMRs Sort no. 2   DN Sort no. l   DN Sort no. 2
  ----------------- --------------- --------------- -------------------- -------------------- --------------- ---------------
  Total clusters    55,860,206      50,236,510      45,620,214           43,638,958           51,801,750      43,045,079
  Usable            42,253,049      38,469,481      34,361,200           32,425,037           39,156,811      32,418,056
  *Splice usable*   9,459,613       8,67,128        7,992,789            7,956,586            9,451,395       7,789,216
  *Genome usable*   32,793,436      29,832,353      26,607,223           25,223,801           29,971,384      25,234,178
  Exon counts       37,491,412      34,400,856      30,327,985           28,750,186           34,988,317      29,045,318
